发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| CHINA MAINLAND | 125 |
| USA | 103 |
| Italy | 65 |
| GERMANY (FED REP GER) | 51 |
| Japan | 51 |
| South Korea | 45 |
| England | 39 |
| Spain | 31 |
| Denmark | 30 |
| Israel | 29 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| CAPITAL MEDICAL UNIVERSITY | 27 |
| SHANGHAI JIAO TONG UNIVERSITY | 23 |
| CHAIM SHEBA MEDICAL CENTER | 20 |
| TEL AVIV UNIVERSITY | 20 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING U... | 18 |
| UNIVERSITY OF COPENHAGEN | 18 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 17 |
| SEOUL NATIONAL UNIVERSITY (SNU) | 16 |
| CATHOLIC UNIVERSITY OF KOREA | 15 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 15 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Prevalence of cardiovascular disease in type 2 diabetes:... | 161 |
| Association between insulin resistance and the developme... | 110 |
| SGLT2 inhibition with empagliflozin attenuates myocardia... | 53 |
| Endothelial dysfunction and platelet hyperactivity in ty... | 42 |
| Effect of metformin on all-cause and cardiovascular mort... | 38 |
| The selective peroxisome proliferator-activated receptor... | 36 |
| Class effects of SGLT2 inhibitors on cardiorenal outcome... | 34 |
| Impact of dapagliflozin on left ventricular diastolic fu... | 34 |
| SGLT-2-inhibition with dapagliflozin reduces tissue sodi... | 33 |
| Diabetes, cardiovascular disease and the microcirculatio... | 33 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CARDIOVASC DIABETOL | 737 |
| INT J MOL SCI | 148 |
| SCI REP-UK | 89 |
| DIABETES OBES METAB | 85 |
| NUTRIENTS | 77 |
| DIABETES THER | 69 |
| J CLIN MED | 52 |
| DIABETES RES CLIN PR | 49 |
| DIABET METAB SYND OB | 48 |
| PLOS ONE | 48 |